IBOGF (Universal Ibogaine) Other Operating Expense: $1.47 Mil (TTM As of Apr. 2025)


What is Universal Ibogaine Other Operating Expense?

Universal Ibogaine IBOGF -1.07% Other Operating Expense is $1.47 Mil as of Apr. 2025.

Universal Ibogaine's Other Operating Expense for the three months ended in Apr. 2025 was $0.38 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Apr. 2025 was $1.47 Mil.

Universal Ibogaine's quarterly Other Operating Expense declined from Oct. 2024 ($0.38 Mil) to Jan. 2025 ($0.31 Mil) but then increased from Jan. 2025 ($0.31 Mil) to Apr. 2025 ($0.38 Mil).

Universal Ibogaine's annual Other Operating Expense increased from Jul. 2022 ($0.65 Mil) to Jul. 2023 ($1.03 Mil) and increased from Jul. 2023 ($1.03 Mil) to Jul. 2024 ($1.55 Mil).

Universal Ibogaine Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Universal Ibogaine's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universal Ibogaine Other Operating Expense Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23 Jul24
Other Operating Expense
Get a 7-Day Free Trial 0.00 0.00 0.65 1.03 1.55

Universal Ibogaine Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.40 0.38 0.31 0.38

Universal Ibogaine Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Apr. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.47 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $1.47 Mil mean?
Universal Ibogaine (IBOGF) has a Other Operating Expense of $1.47 Mil as of Apr. 2025. Other operating expenses that a company records on its income statement. View historical data on Universal Ibogaine and its competitors.
Is Universal Ibogaine's Other Operating Expense too high?
Universal Ibogaine's current Other Operating Expense is $1.47 Mil.
How does Universal Ibogaine's Other Operating Expense compare to LABT and CALC?
Universal Ibogaine's Other Operating Expense of $1.47 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Universal Ibogaine and its competitors. Universal Ibogaine's current Other Operating Expense is $1.47 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universal Ibogaine stock overvalued right now?
Universal Ibogaine (IBOGF) has a current Other Operating Expense of $1.47 Mil. The current Other Operating Expense is $1.47 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Universal Ibogaine (IBOGF), the current Other Operating Expense is $1.47 Mil as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Universal Ibogaine Business Description

Address C/o Cas Corporate Governance Services Inc, 815 - 8th Avenue South west, Suite 600, Calgary, AB, CAN, T2P 3P2
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.